An assessment of the impact of Raman based glucose feedback control on CHO cell bioreactor process development

Author:

Gibbons Luke12ORCID,Maslanka Francis3,Le Nikky3,Magill Al3,Singh Pankaj3,Mclaughlin Joseph1,Madden Fiona1,Hayes Ronan1,McCarthy Barry1,Rode Christopher3,O'Mahony Jim2,Rea Rosemary2,O'Mahony‐Hartnett Caitlin1

Affiliation:

1. Biotherapeutics Development Janssen Sciences Ireland UC Cork Ireland

2. Department of Biological Sciences Munster Technological University Cork Ireland

3. BioTherapeutic Development Janssen Pharmaceutical Companies of Johnson and Johnson Malvern Pennsylvania USA

Abstract

AbstractProcess analytical technology (PAT) tools such as Raman Spectroscopy have become established tools for real time measurement of CHO cell bioreactor process variables and are aligned with the QbD approach to manufacturing. These tools can have a significant impact on process development if adopted early, creating an end‐to‐end PAT/QbD focused process. This study assessed the impact of Raman based feedback control on early and late phase development bioreactors by using a Raman based PLS model and PAT management system to control glucose in two CHO cell line bioreactor processes. The impact was then compared to bioreactor processes which used manual bolus fed methods for glucose feed delivery. Process improvements were observed in terms of overall bioreactor health, product output and product quality. Raman controlled batches for Cell Line 1 showed a reduction in glycation of 43.4% and 57.9%, respectively. Cell Line 2 batches with Raman based feedback control showed an improved growth profile with higher VCD and viability and a resulting 25% increase in overall product titer with an improved glycation profile. The results presented here demonstrate that Raman spectroscopy can be used in both early and late‐stage process development and design for consistent and controlled glucose feed delivery.

Funder

Irish Research Council for Science, Engineering and Technology

Publisher

Wiley

Subject

Biotechnology

Reference37 articles.

1. EckerD CrawfordT SeymourP.The Therapeutic Monoclonal Antibody Product Market – Bioprocess International. Available at:https://bioprocessintl.com/business/economics/the‐market‐for‐therapeutic‐mab‐products/ 30 October 2020 Accessed: 5 June 2021

2. Innovation in the pharmaceutical industry: New estimates of R&D costs

3. Benchmarking biopharmaceutical process development and manufacturing cost contributions to R&D

4. Recent advances in large-scale production of monoclonal antibodies and related proteins

5. Advances in the production and downstream processing of antibodies

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3